KAY FRANK: Open Payments
NPI 1750908562 · FARMINGTON HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,041 in 48 payments from 11 companies in 2025. Trend: 2023 $485 · 2024 $1,269 · 2025 $1,041
Food & beverage: $1,041
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $300 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $228 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $173 |
| Janssen Biotech, Inc. | 4 | $75 |
| GENZYME CORPORATION | 3 | $72 |
| Lilly USA, LLC | 3 | $62 |
| Ardelyx, Inc. | 2 | $42 |
| Intercept Pharmaceuticals, Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $24 |
| PFIZER INC. | 1 | $22 |
Products named: XIFAXAN, ENTYVIO, SKYRIZI, RINVOQ, TREMFYA, DUPIXENT, OMVOH, CREON.
Industry payments across MI — which companies pay providers there.
